CN102341506A - 用于扩增丙型肝炎病毒核酸的方法 - Google Patents

用于扩增丙型肝炎病毒核酸的方法 Download PDF

Info

Publication number
CN102341506A
CN102341506A CN2010800098527A CN201080009852A CN102341506A CN 102341506 A CN102341506 A CN 102341506A CN 2010800098527 A CN2010800098527 A CN 2010800098527A CN 201080009852 A CN201080009852 A CN 201080009852A CN 102341506 A CN102341506 A CN 102341506A
Authority
CN
China
Prior art keywords
seq
nucleotide sequence
nucleotides
independently
primer comprises
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN2010800098527A
Other languages
English (en)
Chinese (zh)
Inventor
A·D·孔
J·D·弗朗兹
D·J·巴陀思
林超
B·施姆斯
S·瑟普索德
J·A·利普克
T·L·基弗尔
Y·周
E·Z·张
J·C·苏利万
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Vertex Pharmaceuticals Inc
Original Assignee
Vertex Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vertex Pharmaceuticals Inc filed Critical Vertex Pharmaceuticals Inc
Publication of CN102341506A publication Critical patent/CN102341506A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/706—Specific hybridization probes for hepatitis
    • C12Q1/707—Specific hybridization probes for hepatitis non-A, non-B Hepatitis, excluding hepatitis D
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2531/00—Reactions of nucleic acids characterised by
    • C12Q2531/10—Reactions of nucleic acids characterised by the purpose being amplify/increase the copy number of target nucleic acid
    • C12Q2531/113—PCR

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Pathology (AREA)
  • Virology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
CN2010800098527A 2009-01-21 2010-01-21 用于扩增丙型肝炎病毒核酸的方法 Pending CN102341506A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US14608309P 2009-01-21 2009-01-21
US61/146,083 2009-01-21
PCT/US2010/021589 WO2010090857A2 (en) 2009-01-21 2010-01-21 Methods for amplifying hepatitis c virus nucleic acids

Publications (1)

Publication Number Publication Date
CN102341506A true CN102341506A (zh) 2012-02-01

Family

ID=42334055

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2010800098527A Pending CN102341506A (zh) 2009-01-21 2010-01-21 用于扩增丙型肝炎病毒核酸的方法

Country Status (13)

Country Link
US (2) US8679740B2 (https=)
EP (1) EP2389452A2 (https=)
JP (1) JP2012515534A (https=)
KR (1) KR20120101278A (https=)
CN (1) CN102341506A (https=)
AU (1) AU2010210892A1 (https=)
CA (1) CA2749969A1 (https=)
IL (1) IL214195A0 (https=)
MX (1) MX2011007693A (https=)
NZ (1) NZ594155A (https=)
RU (1) RU2011134857A (https=)
WO (1) WO2010090857A2 (https=)
ZA (1) ZA201105349B (https=)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106222306A (zh) * 2016-08-30 2016-12-14 合肥金域医学检验所有限公司 一种hcv病毒ns5a蛋白编码序列突变检测试剂盒
CN113614251A (zh) * 2018-12-03 2021-11-05 真实世界诊断有限公司 Hcv检测

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3138078C (en) 2007-10-02 2024-02-13 Labrador Diagnostics Llc Modular point-of-care devices and uses thereof
MX349288B (es) 2011-01-21 2017-07-21 Theranos Inc Sistemas y metodos para maximizacion de uso de muestras.
US8475739B2 (en) 2011-09-25 2013-07-02 Theranos, Inc. Systems and methods for fluid handling
US9632102B2 (en) 2011-09-25 2017-04-25 Theranos, Inc. Systems and methods for multi-purpose analysis
US9664702B2 (en) 2011-09-25 2017-05-30 Theranos, Inc. Fluid handling apparatus and configurations
US20140170735A1 (en) 2011-09-25 2014-06-19 Elizabeth A. Holmes Systems and methods for multi-analysis
US9268915B2 (en) 2011-09-25 2016-02-23 Theranos, Inc. Systems and methods for diagnosis or treatment
US8840838B2 (en) 2011-09-25 2014-09-23 Theranos, Inc. Centrifuge configurations
US9619627B2 (en) 2011-09-25 2017-04-11 Theranos, Inc. Systems and methods for collecting and transmitting assay results
US10012664B2 (en) 2011-09-25 2018-07-03 Theranos Ip Company, Llc Systems and methods for fluid and component handling
US9250229B2 (en) 2011-09-25 2016-02-02 Theranos, Inc. Systems and methods for multi-analysis
US9810704B2 (en) 2013-02-18 2017-11-07 Theranos, Inc. Systems and methods for multi-analysis
MX384530B (es) 2013-09-06 2025-03-14 Labrador Diagnostics Llc Dispositivos, sistemas, metodos y equipos para recibir un hisopo.
SG11201601611WA (en) * 2013-09-06 2016-04-28 Theranos Inc Systems and methods for detecting infectious diseases

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0633321A1 (en) * 1993-06-14 1995-01-11 Immuno Japan Inc. HCV related oligonucleotides and uses thereof in methods for detecting and genotyping of HCV, and kits used in these methods

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4458066A (en) 1980-02-29 1984-07-03 University Patents, Inc. Process for preparing polynucleotides
US4415732A (en) 1981-03-27 1983-11-15 University Patents, Inc. Phosphoramidite compounds and processes
US4973679A (en) 1981-03-27 1990-11-27 University Patents, Inc. Process for oligonucleo tide synthesis using phosphormidite intermediates
DE3329892A1 (de) 1983-08-18 1985-03-07 Köster, Hubert, Prof. Dr., 2000 Hamburg Verfahren zur herstellung von oligonucleotiden
FR2596761B1 (fr) 1986-04-08 1988-05-20 Commissariat Energie Atomique Derives de nucleosides et leur utilisation pour la synthese d'oligonucleotides
US5310652A (en) 1986-08-22 1994-05-10 Hoffman-La Roche Inc. Reverse transcription with thermostable DNA polymerase-high temperature reverse transcription
US5322770A (en) 1989-12-22 1994-06-21 Hoffman-Laroche Inc. Reverse transcription with thermostable DNA polymerases - high temperature reverse transcription
ES2111589T3 (es) 1991-08-27 1998-03-16 Hoffmann La Roche Metodos y reactivos para la deteccion de la hepatitis c.
EP0532258A2 (en) * 1991-09-09 1993-03-17 Immuno Japan Inc. Oligonucleotides and determination system of HCV genotypes
ZA966663B (en) 1995-08-17 1998-02-06 Genentech Inc Traf Inhibitors.
US6153421A (en) * 1997-07-18 2000-11-28 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Cloned genomes of infectious hepatitis C viruses and uses thereof
US6790952B2 (en) * 2001-02-13 2004-09-14 Cincinnati Children's Hospital Research Foundation Quantitative epstein barr virus PCR rapid assay
JP3751867B2 (ja) * 2001-09-18 2006-03-01 株式会社東芝 インターフェロンを投与されるべき個体においてインターフェロン療法の有効性を予測する方法、その方法をコンピュータにより実行させるためのプログラム、インターフェロン感受性に関連する多型部位の遺伝子型を検出するための核酸プローブ、およびその核酸プローブを具備する塩基配列検出用チップ
AU2003230790A1 (en) * 2002-04-03 2003-10-20 Smithkline Beecham Corporation Hepatitis c virus sub-genomic replicons
US20040137539A1 (en) * 2003-01-10 2004-07-15 Bradford Sherry A. Cancer comprehensive method for identifying cancer protein patterns and determination of cancer treatment strategies
BRPI0407587A (pt) 2003-02-18 2006-02-14 Pfizer inibidores do vìrus da hepatite c, composições e tratamentos que os utilizam
US20050282179A1 (en) 2003-12-05 2005-12-22 Applera Corporation Biomarkers for interferon-alpha response in hepatitis C virus infected patients
JPWO2006085407A1 (ja) * 2005-02-09 2008-12-18 学校法人日本大学 Ｈｃｖ量に関連する遺伝子のスクリーニング方法
EP2151495A4 (en) * 2007-04-27 2010-06-02 Advanced Life Science Inst Inc HCV GENE
JP4213759B2 (ja) * 2007-08-10 2009-01-21 株式会社東芝 標的核酸の遺伝子型、および変異の判定方法、不溶性支持体に核酸断片を固定化する方法、所望の核酸を精製し、かつ増幅するための方法、並びに遺伝子型アッセイキット

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0633321A1 (en) * 1993-06-14 1995-01-11 Immuno Japan Inc. HCV related oligonucleotides and uses thereof in methods for detecting and genotyping of HCV, and kits used in these methods

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
KUNTZEN T ET CL: "a set of reference sequences for the hepatitis c genotypes 4d,4f and 4k covering the full open reading frame", 《J MED VIROL》 *
YANAGI M. ET CL: "transcripts from a single full-length cDNA clone of hepatitis c virus are infectious when directly transfected into the liver of a chimpanzee", 《PROC. NATL. ACAD. SCI.》 *
陈玮等: "多重PCR HCV基因分型检测方法的建立及初步应用", 《传染病信息》 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106222306A (zh) * 2016-08-30 2016-12-14 合肥金域医学检验所有限公司 一种hcv病毒ns5a蛋白编码序列突变检测试剂盒
CN113614251A (zh) * 2018-12-03 2021-11-05 真实世界诊断有限公司 Hcv检测

Also Published As

Publication number Publication date
AU2010210892A1 (en) 2011-08-11
WO2010090857A2 (en) 2010-08-12
ZA201105349B (en) 2013-10-30
IL214195A0 (en) 2011-08-31
WO2010090857A3 (en) 2010-11-25
CA2749969A1 (en) 2010-08-12
US20120129155A1 (en) 2012-05-24
KR20120101278A (ko) 2012-09-13
RU2011134857A (ru) 2013-02-27
US20140199684A1 (en) 2014-07-17
JP2012515534A (ja) 2012-07-12
NZ594155A (en) 2013-02-22
EP2389452A2 (en) 2011-11-30
MX2011007693A (es) 2011-09-27
US8679740B2 (en) 2014-03-25
WO2010090857A8 (en) 2012-06-28

Similar Documents

Publication Publication Date Title
US8679740B2 (en) Methods for amplifying hepatitis C virus nucleic acids
AU2008249300B2 (en) Methods and compositions for identifying and characterizing hepatitis C
JP2012515534A5 (https=)
US8945833B2 (en) Method for determining drug resistance mutations in any of the non-structural protein regions NS3 to NS5B of hepatitis C virus (HCV) for genotypes 1 to 6
CN113215308B (zh) 检测人细小病毒核酸和甲型肝炎病毒核酸的组合物和方法
JP2013198486A (ja) Ｈｃｖ遺伝子
JPH07184695A (ja) Ｃ型肝炎ウイルスの簡易検出法
HK1163188A (en) Methods for amplifying hepatitis c virus nucleic acids
US10202659B2 (en) Primers and methods for detecting human hepatitis C virus (HCV) variants in an isolated sample
US20160177407A1 (en) Method for determining drug resistance mutations in any of the non-structural protein regions ns3 to ns5b of hepatitis c virus (hcv) for genotypes 1 to 6
JP2011501953A (ja) Ｈｃｖ遺伝子型タイピングおよび表現型タイピング
US20070299255A1 (en) Compositions and Methods for Amplification and Cloning of Near Full-Length Viral Genome Samples
JP5607532B2 (ja) Ｈｃｖ薬剤抵抗性のほぼ全ゲノムのアッセイ
CN1270228A (zh) 用于有效反转录丙型肝炎病毒(hcv)rna的寡核苷酸引物及其使用方法
Ijaz et al. Prevalence of Genotype 3a Hepatitis C Virus (HCV) In the Infected Population of Lahore, Pakistan
HK40056876A (en) Compositions and method for detecting human parvovirus nucleic acid and for detecting hepatitis a virus nucleic acids
WO2000033635A2 (en) Primer-independent rna synthesis catalyzed by hcv polymerase
Berg et al. Detection of GB virus C RNA by GBV-C LCx and two PCR assays with primers from the 5′ non-coding and NS5B region
KR20070037228A (ko) Ｈｃｖ 특이 유전자 검출키트
KR20060111179A (ko) Ｃ형 간염 바이러스의 유전자형 분석방법

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1163188

Country of ref document: HK

AD01 Patent right deemed abandoned

Effective date of abandoning: 20120201

C20 Patent right or utility model deemed to be abandoned or is abandoned
REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1163188

Country of ref document: HK